Analysts at RBC took the hypothetical case of an investor planning to move $3,000 of cash into a balanced portfolio every year, starting in 2004. An investor with perfect timing would put their funds ...

Back at home, the FTSE 100 is up 0.25 per cent in early trading, with traders still bullish over a potential Bank of England rate cut next month, as data from last week pointed to a fundamentally weak ...

Shares at Midwich Group (MIDW) fell more than 2 per cent this morning after the audio-visual (AV) technology distributor issued yet another profit warning. The company now expects 2024 adjusted ...

A lowly rated intelligent transport systems provider has upgraded guidance for both 2024 and 2025, buoyed by strong order intake from UK government-funded contracts ...

Self-driving car proponents promise a lot of profits, but a handful of companies are competing for pole position ...

The retail news is bitterly disappointing, although not wholly unexpected if you’ve been paying attention to what the ...

How will the labour market react to the Budget's policy changes?

Decades of patient investing have left this reader with substantial assets and a tax headache. Dave Baxter looks at the ...

In terms of our quality metrics, the business is showing good return on invested capital and its operating margins have moved into double-digit territory on a trailing 12-month basis. Strong earnings ...

Smiths Group (SMIN), IG Design (IGR), M&C Saatchi (SAA), DFS (DFS), Evoke (EVOK), McBride (MCB) and Big Yellow Group (BYG) Activist investor Engine Capital called for Smiths Group (SMIN) to be broken ...

Dan Jones hosts a conversation on a FTSE listed games miniatures business, small-cap income stocks and a bovine genetics company ...

While the deals done this week are important for the future direction of the industry – US company Gilead (US:GILD) inked the biggest, paying up to $1.7bn for Leo Pharma’s range of pre-clinical ...